AB
UTMD icon

Amalgamated Bank’s Utah Medical Products UTMD Stock Holding History

Amalgamated Bank’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-95
Closed -$5K – 2765
2025
Q4 		$5K Sell
95
-24
-20% -$1.39K ﹤0.01% 2743
2025
Q3 		$7K Hold
119
– – ﹤0.01% 2638
2025
Q2 		$7K Hold
119
– – ﹤0.01% 2610
2025
Q1 		$7K Hold
119
– – ﹤0.01% 2554
2024
Q4 		$7K Hold
119
– – ﹤0.01% 2627
2024
Q3 		$8K Hold
119
– – ﹤0.01% 2585
2024
Q2 		$8K Hold
119
– – ﹤0.01% 2579
2024
Q1 		$8K Sell
119
-362
-75% -$27.2K ﹤0.01% 2544
2023
Q4 		$41K Sell
481
-36
-7% -$2.99K ﹤0.01% 2340
2023
Q3 		$44K Hold
517
– – ﹤0.01% 2311
2023
Q2 		$48K Buy
517
+45
+10% +$4.24K ﹤0.01% 2345
2023
Q1 		$45K Sell
472
-73
-13% -$6.71K ﹤0.01% 2347
2022
Q4 		$55K Hold
545
– – ﹤0.01% 2379
2022
Q3 		$46K Buy
545
+9
+2% +$794 ﹤0.01% 2499
2022
Q2 		$46K Buy
536
+103
+24% +$8.79K ﹤0.01% 2532
2022
Q1 		$39K Buy
+433
New +$39.8K ﹤0.01% 2586

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's UTMD Position: Q1 2026 in Review

Amalgamated Bank sold out of Utah Medical Products (UTMD) in Q1 2026, closing a stake of 95 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in UTMD in Q1 2022 and held it in 16 quarters. The position peaked at $55K in Q4 2022. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Amalgamated Bank reported no remaining Utah Medical Products position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 95 Utah Medical Products shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Utah Medical Products in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Utah Medical Products position peaked at $55K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.